Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 244-214-4 | CAS number: 21109-95-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicity to birds
Administrative data
Link to relevant study record(s)
Description of key information
Avian toxicity data are available for barium but not for sulfide. Based on the findings by Schwarzbach et al (2006) and Ridgeway and Karnofsky (1952), elevated Ba-concentrations of eggs may result in deformations of the feet.
Key value for chemical safety assessment
Additional information
Sulfide:
As sulfide does not have a potential for bioconcentration/bioaccumulation, secondary poisoning is not relevant. Further, to examine secondary poisoning (or the lack thereof), mammalian data may be considered.
Barium:
Schwarzbach et al (2006) reported levels of trace elements including barium, chromium and mercury in eggs of the California Clapper Rail (Rallus longirostris obsoletus) collected at the San Francisco Bay (South Bay and North Bay) (period: 1992 at S-B and 1998 at N-B):
- Ba-levels in eggs collected at the South Bay ranged from <0.1 to 0.59 μg/g dw, with a mean of 0.34 μg/g; Ba-levels exceeded the detection limit of 0.1 μg/l in 36 of the 38 analysed eggs.
- Ba-levels in eggs collected at the North Bay ranged from <0.2 to 4.1 μg/g dw. Ba-levels exceeded the detection limit of 0.2 μg/l in 8 of the 9 analysed eggs. Further, three embryos with deformities of the feet were found, and these effects were associated with the highest Ba-levels, ranging from 2.2 to 4.1 μg/g.
The mean Ba-concentration of normal, late-stage embryos (n=12) was 0.41 μg/g (range: 0.20–0.59 μg/g), whereas the mean Ba-concentration of deformed, late-stage embryos (n=3) was 3.00 μg/g (range: 2.16–4.13 μg/g). The difference was significant, but it should be noted that similar, significant findings were also observed for other trace elements determined simultanously, i.e., aluminium, chromium, mercury and strontium. Non-deformed late-stage embryos had Ba-concentrations that were similar to the concentration range reported for Light-footed Clapper rails in southern California by Hui et al (2002). Mean Ba-levels of 1.28 and 0.51 μg/g were found in malpositioned and normal late-stage embryos, respectively. However, Ba-levels in eggs were not significantly associated with malpositioning of late-stage embryos. Schwarzbach et al (2006) pointed out that the concentration of Ba (and other trace elements that interact with Ca or phosphate metabolism) was somewhat dependent on the stage of embryo development, with later stages having higher concentrations of these elements. Mobilization of Ba from the shell during embryo development seems likely, because the embryo extracts minerals from the shell for the developing skeleton (Tuan, 1987).
Malformation of the feet was also noted by Ridgway and Karnofsky (1952), who injected barium (as BaCl2) directly into the yolk of 4d or 8d old eggs, or onto the chorioallantoic membrane (CAM). Malformation of the toes occurred irregularly, but was seen in about 50 % of the treated embryos (8d old injection of yolk or CAM administration) that survived to 18 days. None of the embryos injected at 4 days showed toe abnormalities, and no other gross effects were noted on the embryo. However, the direct injection into the yolk or onto the CAM are not relevant uptake routes. The LD50for 4d-old eggs ‘injection in the yolk is >20 mg/egg. For 8d-old egg and administration via the CAM, the LD50values amount to approximately 11 and 0.8 mg/egg, respectively.
Malformation of the feet has not been observed for the other elements significantly elevated in deformed embryos. This may suggest that Ba was responsible for some of the observed malformations in the eggs collected at North Bay (Schwarzbach et al, 2006).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.